Seroepidemiology for Enteric Fever: Emerging Approaches and Opportunities
暂无分享,去创建一个
[1] P. Teunis,et al. Seroincidence of Enteric Fever, Juba, South Sudan , 2022, Emerging infectious diseases.
[2] A. Azman,et al. Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers , 2022, PLoS neglected tropical diseases.
[3] I. Bogoch,et al. Estimating typhoid incidence from community-based serosurveys: a multicohort study , 2022, The Lancet. Microbe.
[4] G. Dougan,et al. Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study. , 2021, The Lancet. Global health.
[5] K. Neuzil,et al. Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial , 2021, The Lancet. Global health.
[6] R. Heyderman,et al. Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children , 2021, The New England journal of medicine.
[7] P. Teunis,et al. Estimation of seroconversion rates for infectious diseases: Effects of age and noise , 2020, Statistics in medicine.
[8] J. Keenan,et al. Seroprevalence of antibodies against Chlamydia trachomatis and enteropathogens and distance to the nearest water source among young children in the Amhara Region of Ethiopia , 2020, medRxiv.
[9] C. Parry,et al. Redefining typhoid diagnosis: what would an improved test need to look like? , 2019, BMJ Global Health.
[10] S. Baker,et al. Ascertaining the burden of invasive Salmonella disease in hospitalised febrile children aged under four years in Blantyre, Malawi , 2019, PLoS neglected tropical diseases.
[11] David L. Smith,et al. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The Lancet. Infectious diseases.
[12] S. Baker,et al. The Relationship Between Blood Sample Volume and Diagnostic Sensitivity of Blood Culture for Typhoid and Paratyphoid Fever: A Systematic Review and Meta-Analysis , 2018, The Journal of infectious diseases.
[13] I. Bogoch,et al. Plasma Immunoglobulin A Responses Against 2 Salmonella Typhi Antigens Identify Patients With Typhoid Fever , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] J. Cano,et al. A cross-sectional seroepidemiological survey of typhoid fever in Fiji , 2017, PLoS neglected tropical diseases.
[15] F. Cutts,et al. Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low‐ and middle‐income countries , 2016, Tropical medicine & international health : TM & IH.
[16] D. Molina,et al. Serodiagnosis of Acute Typhoid Fever in Nigerian Pediatric Cases by Detection of Serum IgA and IgG Against Hemolysin E and Lipopolysaccharide. , 2016, The American journal of tropical medicine and hygiene.
[17] J. Y. Park,et al. Revisiting typhoid fever surveillance in low and middle income countries: lessons from systematic literature review of population-based longitudinal studies , 2015, BMC Infectious Diseases.
[18] J. Andrews,et al. Diagnostics for invasive Salmonella infections: Current challenges and future directions. , 2015, Vaccine.
[19] M. Levine,et al. Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] M. Kretzschmar,et al. A two-phase within-host model for immune response and its application to serological profiles of pertussis. , 2014, Epidemics.
[21] S. Baker,et al. Immunoproteomic Analysis of Antibody in Lymphocyte Supernatant in Patients with Typhoid Fever in Bangladesh , 2013, Clinical and Vaccine Immunology.
[22] D. Huw Davies,et al. Immune profiling with a Salmonella Typhi antigen microarray identifies new diagnostic biomarkers of human typhoid , 2013, Scientific Reports.
[23] Y T H P van Duynhoven,et al. Biomarker dynamics: estimating infection rates from serological data , 2012, Statistics in medicine.
[24] J. Farrar,et al. Kinetics of the Natural, Humoral Immune Response to Salmonella enterica Serovar Typhi in Kathmandu, Nepal , 2009, Clinical and Vaccine Immunology.
[25] P. Teunis,et al. Estimation of incidences of infectious diseases based on antibody measurements , 2009, Statistics in medicine.
[26] S. Wai,et al. Characterization of a Pore-Forming Cytotoxin Expressed by Salmonella enterica Serovars Typhi and Paratyphi A , 2002, Infection and Immunity.
[27] L. Olopoenia,et al. Widal agglutination test − 100 years later: still plagued by controversy , 2000, Postgraduate medical journal.
[28] J. Wain,et al. Value of a Single-Tube Widal Test in Diagnosis of Typhoid Fever in Vietnam , 1999, Journal of Clinical Microbiology.
[29] J. Robbins,et al. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. , 1996, Vaccine.
[30] J. Cross,et al. Diagnostic value of a single, pre-treatment Widal test in suspected enteric fever cases in the Philippines. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.